DalCor Pharmaceuticals US, LLC

CIK 1673368 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for DalCor Pharmaceuticals US, LLC.

Recent SEC filings

FiledFormAccession number
Aug 28, 2026D0001231919-26-001113
Sep 14, 2020D/A0001673368-20-000002
May 27, 2020D0001673368-20-000001
May 12, 2017D/A0001673368-17-000001
May 13, 2016D0001673372-16-000001